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Abstract
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is a toxic halogenated aromatic  hydrocarbon,  which
is a potent toxin to different species such as fish, birds, and mammalians. TCDD  exposure  causes
induction  of  cytochrome   P4501A1   (CYP1A1),   and   that   is   controlled   through   the   Aryl
hydrocarbon  receptor  (AhR).  AhR  is  a  ligand-dependent  cytosolic  protein.   It   is   a   protein
containing basic helix-loop-helix and Per-ARNT-Sim (PAS) domains. It is present  in  the  cytosol
as a complex containing two molecules of heat shock protein (hsp90) and AhR interacting  protein
(AIP).
When TCDD binds to AhR, the ligand–AHR  complex  translocates  to  the  nucleus  and  dissociates  from
chaperone proteins and binds to another protein called ARNT (AhR nuclear translocator). The AhR-ARNT
heterodimer then activates transcription. The  three-dimensional  structure  of  AhR  is  unknown,  as  is  its
interaction with ligands.
The aim of this work is trying to produce a high level expression and purification of an  AhR-GFP
(AhR–green florescent protein) fusion protein functional and sufficient for fluorescence analytical
techniques to study the ligand binding and the change in AhR conformation.
Escherichia coli strain BL21 was used to express the recombinant protein since  it  is  easy,  cheap
and yields a high level of protein. However, the  attempts  were  not  successful  to  express  GST-
EGFP-AhR   (GGA)   and   GST-EGFP-AhR-EGFP   (GGAG)   recombinants   in    a    functional
conformation. By lowering the cultivation temperature, the proteins could be  expressed  and  fold
correctly in E. coli. However, E. coli does not contain the chaperon  proteins  essential  for  ligand
binding. Therefore, the bacterially expressed protein was refolded in human reticulocyte lysate.
This study established that GFP AhR (LBD) recombinant protein  can  be  obtained  in  the  ligand
binding conformation through the expression of the  protein  in  E  coli  followed  by  refolding  in
reticulocyte lysate.
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Introduction
Humans and animals are daily exposed to a large number  of  chemical  compounds  and
environmental pollutants present in the environment, such as drugs,  agrochemicals  and
other environmental contaminants. All of these chemicals  are  detoxified  and  eventually
should be excreted from the body. Many of these chemicals require modification to be  in
a soluble form to enable excretion. The Cytochrome P450 family are the  major  enzymes
involved in these metabolic mechanisms (Lash, 1994)
 Aromatic hydrocarbons are environmental contaminants,  which  cause  toxic  effects  or
diseases in both humans and other animals. There are many examples of  the  effects  of
these hydrocarbon compounds  in  humans  and  animals  such  as  immunosuppression,
cleft palate, chloracne, cancer and heart disease (Birnbaum, 1994).
Many  of  these  chemicals  have  a  similar  toxic  response,   and   act   by   a   common
mechanism through cytochrome P450, such as CYP1A1 to enhance detoxification  which
is controlled  by  a  cytosolic  protein  receptor  called  Aryl  hydrocarbon  receptor  (AhR)
(Knutson and Poland, 1982; Whitlock, et al. 1996; Hahn, 1998).
1 Xenobiotic metabolism
A series of metabolic reactions modifies the chemical structure of xenobiotics,  to  enable
excretion  of  these  compounds.  These  can  be  divided  into  three  phases.   Phase   I
reactions are catalysed by enzymes such as cytochrome  P450.  Phase  II  reactions  are
catalysed by transferase enzymes such as glutathione S-transferases.  Finally,  in  phase
III, the conjugated xenobiotics resulting from Phase I  and  Phase  II  need  to  be  further
processed, before being recognised and excreted from cells, for example by transforming
glutathione conjugates to acetylcysteine.
1.1.2 Cytochromes P450
Cytochrome P450s form a group of enzymes involved in the metabolism of many  clinical
and toxic chemicals.  They  are  also  involved  in  many  metabolic  reactions  of  various
endogenous products such as steroids, and fat-soluble vitamins (Keeney and Waterman,
1993; Higashi et al.,1991; White et al., 1994).
This group of enzymes is responsible for catalysing a number of  detoxification  reactions
called  Phase  I  xenobiotic  reaction.  These   include   epoxidation,   N-dealkylation,   O-
dealkylation, S-oxidation and hydroxylation.
The main goal of the detoxification process is to convert the inactive compound to a form to be  readily
excreted  out  of  the  body.  However,  many  of  these  reactions  can   convert   inactive
molecules to highly polar forms which can be carcinogenic. One of the P450 members  is
CYP1A1, also known as AHH (aryl hydrocarbon hydroxylase); this enzyme is involved  in
the metabolic activation of  aromatic  hydrocarbons.  For  example,  benzo[a]pyrene  is  a
hydrocarbon compound with a link to causing lung cancer (Denissenko et al 1996). In the
metabolic  reaction  of  benzo[a]pyrene,  the  benzo[a]pyrene  oxidation  is  catalysed   by
CYP1A1 to form BaP-7,8-epoxide; hydrolysis of BaP-7,8-epoxide  by  epoxide  hydrolase
(EH) forms BaP-7,8-dihydrodiol which is finally  oxidized  by  CYP1A1  to  form  BaP-7,8-
dihydrodiol-9,10-epoxide, which is the  ultimate  carcinogen  and  can  covalently  bind  to
DNA (Figure 1.1) (Beresford, 1993). The expression of the CYP1A1  is  regulated  by  the
aryl hydrocarbon receptor (Poland and Knutson, 1982).
Figure 2.1 Formation of an Ultimate Carcinogen from benzo[a]pyrene
1.2 Aryl hydrocarbon Receptor (AhR)
AhR is a ligand-dependent cytosolic transcription  factor  that  mediates  the  induction  of
cytochrome P450 family members.  AhR is classified as a member of the basic helix-loop-
helix/Per-ARNT-Sim  (bHLH/PAS)  family  (Fukunaga  et  al.,  1995;   Gu   et   al.,   2000;
Hankinson,  1995).  It  is  present  in  the  cytosol  as  a  complex  and  interacts  with  co-
chaperone proteins,  including  AhR  interacting  protein  (AIP)  (Gu  et  al.,  2000),  which
facilitate  signalling  by  the  AhR  and  play   an   important   role   in   regulating   nuclear
translocation (Ma and Whitlock,  1997;  Whitlock  et  al.,  1996).  Two  molecules  of  heat
shock protein (hsp90) and the co-chaperone p23 were found  to  be  associated  with  the
non activated form of the Aryl hydrocarbon receptor  (Kazlauskas  et  al.,  1999;  Ma  and
Whitlock, 1997).
1.2.1 Identification of the Ah receptor
 Several studies defined the role of AhR in the toxicity and  the  mechanism  of  action  of
HAHs    (Halogenated    Aromatic    Hydrocarbons)    and    PAH    (Polycyclic    Aromatic
Hydrocarbons) including the toxicity of TCDD and related HAHs (Safe 1990;  Poland  and
Knutson 1982).
The  responses   to   dioxin,   related   halogenated   hydrocarbons   compounds   and   polycyclic   aromatic
hydrocarbons are not the result of a covalent chemical reaction of the toxin itself, and the Ah  receptor
mediates the toxic effects of TCDD  (Poland  and  Knutson,  1982).  The  AhR  has  been
reported to exist in several  human  and  animal  tissues  including  placenta,  liver,  lung,
thymus, and fetal kidney.  [3H]  TCDD  ligand-binding  assay  experiments  confirmed  the
existence  of  a  cytosolic  protein  that  binds  specifically  to  radio-labelled   TCDD   and
mediates the induction of CYP1A1  (Allen  et  al.,  1975;  Poland  et  al.,  1986).  In  1996
Gonzalez and  Fernandez-Salguero  reported  that  AhR-Deficient  Mice  are  resistant  to
TCDD  toxicity.  These  studies  provided  the  evidence  of  the  existence   of   the   AhR
(Fernandez-Salguero et al., 1996).
1.2.2 The AhR locus
There   is   genetic   variation   in   the   inducibility   of   CYP1A1   the   response   to    3-
methylcholanthrene (MC) varies significantly among different mouse strains, such that  in
some  strains  there  is  no  induction  of  CYP1A1  (nonresponsive  mice)   (Poland   and
Knutson 1982). These genetic differences in the inducibility of CYP1A1 are controlled  by
the  Ah  locus  and  two  alleles  were  defined,  Ahb  in  responsive  strains   and   Ahd   in
nonresponsive strains (Nebert and Jensen, 1979). TCDD  and  HAH  related  compounds
were capable of inducing CYP1A1 in both responsive  and  nonresponsive  mice.  It  was
suggested that a mutation in nonresponsive mice results in a defect in the structural gene
that encodes for a receptor for TCDD (Poland and Glover, 1979).
The AhR locus encodes the structural  gene  for  the  AhR,  and  the  human  AhR  gene  has  been
localized  to  human  chromosome  7  (Bertrand   et   al.,   1995).   In   mouse,   a   region
homologous to the human AhR gene has been localized on chromosome  12  (Poland  et
al., 1987).
1.2.3 AhR ligands
AhR is also known as the dioxin receptor because of  the  ability  to  activate  the  AhR  in
presence of very small amounts of dioxin. However, there are many chemicals which  are
considered as AhR ligands. AhR ligands could be exogenous or could be endogenous.
1.2.3.1 Exogenous ligands
These  compounds  are  produced  through  incomplete  combustion  of  various   carbon
sources such as diesel exhaust, cigarette smoke, and fried foods (Schmidt  et  al.,  1996;
Sorensen et al., 1996).  These  compounds  can  be  divided  into  halogenated  aromatic
hydrocarbons (HAHs) and polyaromatic hydrocarbons (PAHs).
1.2.3.1.1 Halogenated Aromatic Hydrocarbons (HAHs)
HAH compounds are extremely dangerous and can have a  significant  impact  on  health
because    of    their    ubiquitous    distribution,    fat    solubility,     and     resistance     to
degradation. HAHs have a relatively high binding affinity for the  AhR  (in  the  pM  to  nM
range).  However,  the  majority  of  these   chemicals   are   relatively   weaker   inducers
compared with TCDD.  These  include  the  polychlorinated  dibenzo-p-dioxins  (PCDDs),
dibenzofurans and biphenyls and related chemicals (Safe, 1990). There are  75  possible
congeners  of  chlorinated  dioxin  and  their  properties  depending  on  the  number  and
position of chlorine atoms (Poland and Knutson, 1982).  TCDD  is  one  of  the  important
dioxin congeners which is extremely toxic to  different  species  such  as  fish,  birds,  and
mammals.
1.2.3.1.2 Polycyclic Aromatic hydrocarbons (PAHs)
These chemicals are known to be less potent than HAHs and have lower  binding  affinity
to the AhR  compared  to  the  HAHs.  PAHs  are  among  the  most  widespread  organic
pollutants, formed by incomplete combustion of carbon-containing  fuels  such  as  wood,
coal,    diesel,    fat,    tobacco,    or    incense.    These    include     benzo(a)pyrene,     3-
methylcholanthrene (3MC) and aromatic amines and other related chemicals  (Poland  et
al., 1976).
1.2.3.2 Endogenous ligands
Activation of the AhR signalling pathway  was  observed  in  the  absence  of  exogenous
ligands in several studies (Chang and Puga 1998). Using AhR-null mice, the  role  of  the
AhR  in  normal  development  was  investigated.  Various   physiological   changes   and
developmental   abnormalities   were   detected   in   these   mice,   for    example    early
hepatovascular defects lead to a number of physiological and morphological  changes  in
the adult mouse liver (Schmidt and Bradfield 1996).
A number of natural compounds have been considered  as AhR ligands including derivatives of  tryptophan
such as indigo and indirubin (Adachi et al., 2001),  tetrapyrroles  such  as  bilirubin  (Sinal  and
Bend, 1997), the arachidonic acid metabolites lipoxin A4 and prostaglandin G  (Seidel  et
al., 2001), and a modified low-density  lipoprotein  (McMillan  and  Bradfield,  2007).  The
role  of  these  chemicals  remains  unclear  but  these  chemicals  are  present  in   many
species and tissues.
1.2.4 Toxicity of AhR ligands
Polychlorinated dioxins are normally stored in fatty tissues and it has been estimated that
the half-life of the polychlorinated dioxins  in  a  human  adult’s  body  is  approximately  7
years (Geyer et al. 2002). Their toxicity depends on a number of  factors,  such  as  dose,
age, sex, animal strain and species (Poland and Knutson 1982). Toxicity of TCDD  differs
among species. For example, the acute oral  LD50  dose  for  the  guinea  pig  is  1  ?g/kg
whereas for hamsters it is 5000 ?g/kg. In humans, a high- level exposure to TCDD  leads
to chloracne which is the common effect in human.   This  effect    was  also  observed  in
some laboratory animals such as  rhesus  monkeys  and  rabbits  after  TCDD  exposure.
However, it was not reported in other laboratory animals such as rats, hamsters and mice
(Poland and Knutson 1982).
It has been confirmed that TCDD is carcinogenic in rats and it is a very potent tumour promoter.  Pitot  and
his  colleagues  in  1980  studied  the  possible  effect  of  TCDD  on  rats  as  a   hepatocarcinogenic
promoter;   the   animals   were   exposed   firstly   to   a   single    dose    of    10    mg/kg
diethylnitrosamine followed by doses of TCDD between (0.14 to 1.4 µg/kg) each 14  days
for  7  months.  Nearly  70%  of  the  treated  rats  were  noticed  to  have   hepatocellular
carcinomas. However,  TCDD  is  not  considered  as  genotoxic  since  it  does  not  bind
covalently to protein or nucleic acid (Greenlee and Poland 1979).
PAHs were shown to be  AhR  ligands  and  exposure  to  PAH  may  contribute  to  induction  of
mouse mammary carcinoma through inducing cytochrome p450  family  members  which
oxidize PAH to mutagenic and carcinogenic intermediates (Trombino  et al. 2000).
Creation of AhR deficient mice  confirmed  that  toxicity  of  TCDD  depends  on  AhR.  These  mice  were
resistant and had no response to 10 times  the  dose  of  TCDD  which  was  highly  toxic  in  normal  mice.
However, these mice exhibited  a  number  of  abnormal  phenotypes  including  reduced  liver  weight  and
portal fibrosis associated with accelerated rates of apoptosis (Schmidt et al. 1996).
1.2.5 Structure of the AhR
AhR is classified as a member of the  basic  helix-loop-helix/Per-ARNT-Sim  (bHLH/PAS)
family. AhR contains several domains essential for AhR  function and classification.   The
bHLH region located in the N terminus of the protein is a common region in a  number  of
bHLH  super  family  members.  bHLH  is  a   region   involved   in   AhR-ARNT   complex
dimerization, binding to heat shock protein  and DNA binding  (Gu  et al., 2000).
bHLH region  has  Nuclear Localisation Sequence  (NLS) and  Nuclear Export  Sequence
(NES) domains  located in this region (Berg and Pongratz  2001;  Ikuta   al.,  1998).  This
domain is also necessary for heterodimerization to ARNT and binding of  the  AhR-ARNT
complex to the dioxin response elements (DRE) and activation  of target genes  (Landers
and Bunce, 1991; Fukunaga et al., 1995).
The PAS regions contain two PAS  domain  (Figure  1.2);  the  PAS-A  and  PAS-B  domains  are
known to  enhance  interactions  with  other  PAS  domain  containing  proteins,  such  as
interaction between AhR  and  ARNT.  The  PAS-B  domain  has  an  important  function,
namely to bind to ligand (Denison et al. 2002).
A Q-rich domain is located in the C-terminal region of the AhR protein and is  responsible  for  interactions
with the general transcriptional activation machinery (Fukunaga  et  al.,  1995).  AhR  proteins  have
been characterized in several  mammals  and  there  are  considerable  variations  in  the
structure among different  species,  and  among  strains  within  species  (Poland   et  al.,
1976).
Figure 1.2 cartoon representation of the domain structure of the AhR
1.2.5.1 Ligand binding domain (LBD)
The function of the Ligand Binding Domain region is critical  for  binding  both  the  ligand
and hsp90. It is believed that LBD region is responsible for the correct folding of the  AhR
and  the  maintenance  of  the  three  dimensional  structure   in   a   high   ligand   affinity
conformation.
 In a study to identify the functional domains of the AhR  ,  deletion  of  the  PAS-A  region  (amino
acids 121-182) was shown to reduce ligand binding by a  third,  whereas  deletion  of  the
PAS-B region (amino acids 259-374) entirely eliminated binding to the  ligand,  the  same
response as complete deletion of PAS region. Accordingly, the LBD region was  localised
between amino acids 230 and 397 which includes PAS-B region (Fukunaga et al., 1995).
The LBD has similar affinity for TCDD binding as the full-length AhR (Coumailleau  et  al.,
1995). Therefore, LBD could be a useful to use LBD as a tool in studying the  function  of
the AhR.
1.2.5.2 AhR Signaling Pathway
Ligand-free AhR is present in the cytoplasm as  an  inactive  protein  complex  containing
the AhR (figure 1.3), two molecules of Hsp90, and a single  molecule  of  AhR  interacting
protein (AIP) (Gu et al. 2000). Following the ligand binding AhR  conformational  changes
take  place  leading  to  unveiling  of  the  nuclear  localization  sequence,  and  then   the
ligand–AhR  complex  translocates  to  the  nucleus  (Pollenz  et   al.   1994).   Once   the
ligand–AhR complex enters  the  nucleus,  the  AhR  dissociates  from  the  complex  and
dimerises with ARNT (Dzeletovic et al. 1997).
This dimerisation alters the AhR into a high affinity  DNA  binding  structure  and  enables
AhR to bind DNA Xenobiotic Response Elements XRE  (Dioxin  Response  Elements,DRE)
of target promoters. (Dzeletovic et al. 1997). Binding of  the  Ligand-AhR-ARNT  complex
to this region enhances the transcription of several genes, including CYP1A1,  known  as
the AhR gene battery (Durrin and Whitlock 1989).
However, the AhR signaling pathway is still not fully understood  because  of  the  lack  of
information  about  the  molecular  mechanism  of  how  the  AhR  signalling  pathway   is
activated and structural information about AhR  LBD  and  the  interaction  between  AhR
and chaperone proteins such as AIP and Hsp90.
Figure 1.3 Cartoon explaining the AhR Signaling Pathway (Gu, Hogenesch et al. 2000).  (A)
Unbound AhR protein complex containing two molecule of Hsp90, and a single molecule  of  AIP.
(B) Ligand binding to the AhR complex. (C) AhR dissociates from the complex and dimerises with
ARNT (D) AhR/ARNT complex binds to DNA in DRE region
1.3 Chaperones of Non-ligand bound AhR
The Cytosolic AhR interacts with a number of chaperone  proteins,  including  AIP,  which
facilitates  signalling  by  the  AhR  and  plays  an  important  role  in   regulating   nuclear
translocation (Ma and Whitlock 1997) and two molecules of Hsp90 and the co-chaperone
p23. Hsp90 interacts with  p23  forming  a  dimer,  this  dimer  has  several  crucial  roles,
including  protection  of  the  AhR  from  proteolysis,  conservation  of   the   AhR   pocket
conformation   to   enable   ligand   binding   and   to   prevent   untimely   ARNT   binding
(Kazlauskas et al., 1999).
 1.3.1 Heat shock protein 90 (Hsp90)
Hsp90 is a chaperone protein abundant in the cytoplasm, and represents about  1-2%  of
the total expressed proteins in the cell.  Hsp90  was  found  in  eukaryotic  cells  and  it  is
necessary for cell viability (Pearl  and  Prodromou,  2001;  Richter  and  Buchner,  2001).
Hsp90 acts as chaperone protein and is essential for protein folding and function (Pratt et
al., 2004).
1.3.1.1 The role of hsp90 in AhR signalling
It has been established  that  Hsp90  is  a  critical  protein  for  the  AhR  ligand  signaling
pathway, and is consistent with the normal function of the Hsp90 as a chaperone  protein
(Pongratz et al., 1994). Separation of the Hsp90 from the AhR leads to incapability of  the
AhR to bind the ligand; when Hsp90 was reduced by nearly 95%, AhR failed to  response
to the ligand (Carver and Bradfield, 1997; Whitelaw et al., 1995; Perdew, 1988).
There are two regions in the AhR where Hsp90 interacts with AhR; these are the  LBD  region  (the  region
between amino acids 230 to 421) and the bHLH region (Whitelaw  et  al.,  1994;  Antonsson  et  al.,
1995).
Hsp90 has a number of important functions in term of AhR signalling and  binding  to  the
ligand. The first one is  to  maintain  the  AhR  in  a  high-affinity  conformation  state  and
properly fold the receptor in a conformation suitable for ligand  binding  (Swanson  et  al.,
1993; Pollenz et al., 1994). Exposure of the Hsp90 to a high  temperature  and  high  salt
dissociated Hsp90 from the AhR and abolished binding of ligand (Grenert et al., 1997).
The Second function of Hsp90 is to prevent the AhR from binding to  ARNT  (McGuire  et
al., 1994). The other function for the Hsp90 is to unmask  the  nuclear  localisation  signal
(NLS) which exists in the N-terminus of the AhR targeting the AhR  to  the  nucleus.  This
step is important to translocate the AhR to the nucleus (Ikuta et al., 1998).
1.3.2 AhR interacting Protein
AIP is also called X-Associated Protein 2 (XAP2)  (Kuzhandaivelu  et  al.,  1996)  or  AhR
associated protein 9 (ARA9) (Carver and Bradfield,  1997).  This  protein  belongs  to  the
Immunophilin family, which has peptidylprolyl isomerase (PPIase) activity.
 In the N-terminal region of this protein, there is a peptidylprolyl isomerase domain  and  in  the   C-
terminal region, there are three tetratricopeptide (TPR) repeat motifs; these are 34-amino
acid residue repeats which  provide  the   ?-helical  structure  for  this  unit  and  form  the
protein/ protein interaction domain   (Pratt et al., 2004; Pratt et al., 2004) .
The C-terminal region is necessary for the interaction  with  both  the  AhR  and  other  chaperone  proteins
(Bell and Poland 2000). A study performed by  Bell  and  Poland  in  2000,  mutating  the  conserved  basic
residue in TPR of AhR interacting protein, proposed that this region was  essential  for  binding  both  AhR
and Hsp90 (Bell and Poland, 2000). The LBD region in the AhR is  essential  for  binding  to
AIP. In the Hsp90, the C terminus region is essential to bind AIP (Bell and Poland, 2000).
1.3.2.1 The role of AIP in AhR signalling
AIP is important  in  enhancing  the  AhR  transcriptional  activity  through  increasing  the
stability of the AhR and protecting the  unbound  AhR  from  degradation  (LaPres  et  al.,
2000), (Kazlauskas et al., 2000), (Ma and Baldwin, 2000), (Lees and Whitelaw, 2002).  In
addition,  AIP  localizes  AhR  in  the   cytoplasm.   Recent   studies   showed   that   over
expression of AIP redistributes the AhR to the cytoplasm (LaPres et al., 2000; Petrulis  et
al., 2000; Petrulis and Perdew, 2002). AIP is thought to connect the unbound AhR to  the
actin filaments to stabilize the AhR in the cytoplasm (Petrulis et al., 2003). Moreover; AIP
reduces the binding of the nuclear localisation signal (NLS) to Importin and prevents AhR
from entering the nucleus (Kazlauskas et al., 2001; Petrulis and Perdew, 2002).
1.3.3 P23 or Hsp90-associated protein
The p23 is a ubiquitous, highly conserved protein, which interacts with Hsp90  (Pratt  and
Toft, 1997), and is also called Hsp90  binding  protein  (Johnson  et  al.,  2000).  The  p23
binds to the N-terminal region of Hsp90 to stabilize  the  interaction  between  the  Hsp90
and  the  receptor  which  enhances   the   frequency   of   receptor   in   the   high-affinity
conformation (Pratt and Toft, 1997; Cox and Miller, 2002).
  p23 is necessary for dimerizing  the two units of   Hsp90  and  formation  of   the  cytosolic  complex;
also it has an important role in dimerizing  AhR to ARNT.  p23 binds to  the  ATP  binding
region  in  Hsp90   and  acts  as  substrate  releasing  factor  (Kazlauskas  et  al.,   2001);
releasing  Hsp90  form  the  AhR  depends  on  the   Hsp90   ATPase   activity   which   is
stimulated by p23  (Kazlauskas et al., 1999; Young  and  Hartl,  2000).  Also,  it  interacts
with other  proteins  to  maintain  them  in  a  folding-form  stage  (Freeman  et  al.,  1996;
Freeman and Morimoto, 1996). However, a recent study  has  demonstrated  that  p23  is
not required in vivo as co-chaperone protein in AhR binding  or  targeting  (Murray  et  al.,
2009).
 1.4 AhR activation and protein folding
Non-functional proteins result  from  incorrect  folding  (misfolding)  (Shortle,  1997).  AhR
responses to different ligands depend on the primary structure of the AhR. This  fact  was
demonstrated  by  site-directed  mutations  within  the  LBD  of  mouse  AhR   in   specific
residues;  one  mutation  changed  the  response  to  antagonist  (Henry  and  Gasiewicz,
2008).  A  study  conducted  by  Backlund  and  Ingelman-Sundberg  (2004)  on  mutated
residues in the LBD of Gal4-AhR, revealed that high- and low-affinity ligands interact with
different residues in the  AhR  ligand-binding  pocket.  There  are  specific  structural  and
chemical requirements for ligand binding. A previous study has attempted  to  investigate
the structure of the AhR; (Pandini et al., 2007)  developed  a  model  of  the  mouse  AhR
PAS B domain by comparative modelling techniques.
The PAS domain structures of the functionally related hypoxia-inducible  factor  2R  (HIF-
2R) and AhR nuclear translocator (ARNT) proteins,  which  show  the  highest  degree  of
sequence similarity with AhR, were chosen as a model to develop a  two-template  model
of  the  PAS  B  domain.  Moreover,  these  models  were  tested  by  using   site-directed
mutagenesis of amino acids  in  key  positions  within  these  models  then  a  model  was
proposed and it suggesting some key features required for ligand binding (Pandini et  al.,
2007).
A similar study  was  conducted,  based  on  the  similarity  of  PAS  domain  structure  of
hypoxia-inducible factor and AhR LBD, to generate a homology model of the mouse AhR-
LBD based on its similarity (Bisson et al., 2009). However, these attempts were based on
virtual ligand screening and did not demonstrate the real structure and the exact features
of the LBD AhR binding cavity. Also, these studies proposed that AhR LBD  receptor  has
the highest affinity binding conformation, and  it  may  be  that  the  LBD  AhR  has  lower
affinity than the ideal proposed.
 The structure of AhR has not been determined. No X-ray or NMR- study has demonstrated the structure of
bound or unbound AhR. The difficulty is the expression of the functional AhR in sufficient amounts. Trials
to express AhR in bacteria were carried out since bacterial systems are  cheaper,  on  the  other  hand,  AhR
can be expressed with ligand-binding functionality in reticulocyte lysates, but the amount of AhR produced
was very minimal - approximately 20 ?g of purified protein (Burbach et al., 1992).
 1.5 AhR-GFP (AhR –green florescent protein) fusion protein
This  work  followed  the  Shaikh-Omar  (2006)  study,  in  order  to  obtain  a   high   yield
expression of functional AhR in bacteria. In that study  three  plasmids  were  constructed
based on pET41b. The  first  one  (GG)  contained  enhanced  green  fluorescent  protein
(EGFP) tagged to glutathione S-transferase (GST), the  second  (GGA)  contained  GST-
tagged AhR LBD with EGFP  and  the  third  construct  (GGAG)   contained  GST-tagged
mouse AhR LBD with two EGFP (Figure 1.4). Shaikh-Omar (2006) attempted to  express
GGA and GGAG recombinants in BL21 D3 at 37oC and his efforts to express  and  purify
these recombinants did not produce  any  success  in  obtaining  functional  protein;  SDS
PAGE showed no band  in  the  soluble  fraction,  possibly  because  there  was  no  soluble
protein, or a  very low concentration of the expressed protein. However,  expression  and
the purification of GG recombinant were successful.
Figure 1.4  Cartoon  of GG,GGA and GGAG protein  constructs  .These  constructs  contain  Enhanced
green  fluorecent  protein  (EGFP)  tagged  to  glutathione  S-transferase  (GST)  and  AhR  ligand   binding
Domain (AhR-LBD)
1.6 The aim of this work
The aim of this work is to investigate the  structure  of  AhR  by  examining  an  AhR-GFP
(AhR–green fluorescent protein) fusion protein which has enhanced  solubility  compared
with other bacterially expressed AhR constructs.
The aim of this work is to
• To express AhR LBD in E. coli (arctic express), which has chaperone proteins that
could help AhR folding.
• To examine the solubility and functionality of the LBD-AhR constructs
• In the case of  non-functional  protein,  to  refold  the  soluble  AhR  in  reticulocyte
lysate
• To purify  the  fusion  proteins  and  with  any  associated  chaperone  protein  using
GST affinity tags.
Materials and methods
2.1 Material
 2.1.1 Chemical
All reagents and chemicals were obtained  at  highest  standard  commercially  available.
Bovine serum albumin  (BSA),  dithiothreitol  (DTT),  ethidium  bromide,  sodium  dodecyl
sulphate (SDS), and TEMED  (tetramethylethylenediamine)  were  obtained  from  Sigma
Chemical Co. Glacial acetic acid, methanol, NaCl, and  NaOH,  were bought from  Fisher
Scientific UK  Limited.  Glycerol  was  from  Courtin  &  Warner.  bromophenol  blue,  and
ethanol were obtained from BDH. Agarose was from Boehringer Mannheim.
Brilliant blue G was from Aldrich. ammonium persulphate, coomassie brilliant blue R-250 and
hydrochloric acid were obtained from ICN Flow. 30% acrylamide/bisacrylamide was  from
Severn Biotech Ltd. 1Kb plus DNA ladder was from Gibco BRL. 6H  protein  marker  was
from Sigma.
2.1.2 Buffers
 MN stock buffer (pH 7.5 at 4ºC) consists of: 25 mM MOPS and 0.02% sodium azide.
 MEN stock buffer (pH 7.5 at 4ºC) consists of: MN buffer with 1 mM EDTA.
 MDENG stock buffer (pH 7.5  at  4ºC)  consists  of:  MEN  buffer  with  10  %  (w/v)  glycerol,1  mM
dithiothreitol  (DTT),  (DTT  is  freshly  supplemented  to  the  buffer  before   the   protein
preparation) and 20 mM EDTA.
 1X TBS buffer consists of 20 mM Tris-HCl (pH 7.5), 500 mM NaCl (pH8.0).
1X  PBS  buffer  consists  of   137   mM   NaCl,   2.7   mM   KCl,   100   mM   Na2HPO4,   and   2   mM
KH2PO4 (pH7.5).
2.1.3 Media
Lysogeny broth (LB) 1 liter of LB contain10 g tryptone, 5 g yeast extract and 10 g NaCl.
LB plates LB broth + 15 g/litre.
SOC medium (Super Optimal Broth) one litre of SOC contains Bacto-tryptone  20 g,  Bacto-
yeast extract  5 g NaCl 0.5 g,1M KCl 2.5 ml and ddH2O 1000 ml.
2.2 Methods
2.2.1.1 Miniprep of Plasmid DNA
Plasmids were transformed into JM109  as  described  in  section  2.2.2  below.  A  single
colony was picked up into 25 ml LB broth containing appropriate antibiotic and  incubated
overnight at 37oC shaking at 240 rpm. QIA prep Spin Miniprep kit (Qiagen)  was  used  to
purify the plasmids. Following the manufacturer’s instructions, 1 ml  was  taken  from  the
overnight incubated culture of JM109  cells  containing  appropriate  selective  antibiotics.
The cells were then transferred to an Eppendorf tube and centrifuged.
The pellet was resuspended with 250 ?l P1 and then 250?l of P2 buffer  was  added  and
the tube was inverted gently 4-6 times. Immediately, 350?l of N3 buffer was added to  the
mixture and inverted gently 4-6 times. The mixture  was  then  spun  at  14,000  g  for  10
minutes. The supernatant was transferred to the QIA prep spin column and centrifuged at
14,000 g for 1 minute and the flow-through was discarded.
Using 750?l of PE Buffer, the column was washed and centrifuged for 1 minute. After the
flow-through was discarded the QIA column was spun additionally for 1 minute to remove
any remaining washing buffer (PE). The DNA was eluted by adding  50?l  of  sterile  UHP
water to the centre of the column.
2.2.1.2 Restriction digestion of the Plasmids
The plasmids were digested  using  EcoR?  restriction  digestion  enzyme  with  1  µl  10x
Buffer 4, 6.5 µl H2O,  2  µl  DNA,  0.5  µl  enzyme  and  0.1mg/ml  BSA  according  to  the
manual. The mixture was incubated at 37 oC in a water bath for one hour.
2.2.1.3 Agarose Gel Electrophoresis
 50 ml of 1% agarose gel was prepared by adding 0.5 g agarose powder to 50 ml of  TBE
buffer, and then the mixture was microwaved at 50% power for 1-5 minutes. The solution
was transferred into a water bath at 60 oC then loaded into the gel  cassette  and  left  for
20 minutes  at  room  temperature  to  settle.   The  plasmid  samples  were  prepared  by
adding 1 volume of  5x  DNA  loading  buffer  per  5  volumes  of  plasmid  samples.  The
sample and DNA Marker (1Kb plus) were loaded on to the gel and run for 30 min  at  100
V. The gel was then stained with ethidiim bromide stain and visualized under UV.
2.2.2 Transformation
2.2.2.1 Transformation of calcium chloride competent cells
 A Single colony of the bacteria was picked up into 5 ml LB broth  containing  appropriate
antibiotic and incubated overnight at 37 oC shaking at 240 rpm. Next day the culture  was
moved to 50 ml LB broth for 3  to  4  hours  with  shaking  at  240  rpm.  The  culture  was
cooled on ice for 15 minutes then spun for 10 min at 4000g at 4  oC.  The  pellet  was  re-
suspended in 50ml 0.1 M CaCl2. The cell centrifugation  was  repeated  four  times.  After
the final centrifugation it was resuspended in 2 ml 0.1 M CaCl2.
A 1 µl sample of each construct was added to 100 µl of the competent cells and incubated  on  ice
for 30 min followed by 90 seconds at 42 oC and again  on  ice  for  two  minutes.  A  1  ml
aliquot of SOC medium was added to the cells and incubated at  37  oC  for  45  minutes.
200  µl  of  the  cells  were  spread  on  LB  plate  containing  appropriate   antibiotic   and
incubated at 37 oC overnight.
2.2.2.2 Transformation of electro-competent cells
A single colony of the bacteria was picked up into 5 ml  LB  broth  containing  appropriate
antibiotic and incubated overnight at 37 oC shaking at 240 rpm. The next day  the  culture
was diluted to 50 ml LB broth and left for  3  to  4  hours  with  shaking  at  240  rpm.  The
culture was cooled on ice for 15 min and then centrifuged for 10  minutes  at  4000g  at  4
?C. The pellet was re-suspended in 250 ml ice cold ultra highly purified water three times.
 After final centrifugation the pellet was re-suspended in twice its volume of ice cold UHP-water.  A
1 µl sample of each construct was added to 70 µl of the competent cells and placed  in  a
1 mm gap electroporation cuvette and electroporated at a voltage of 1.5 kV.
The cells were then incubated in SOC medium at 37 ?C for 45 minutes.  A 200  µl  aliquot
of the cells was spread on an LB plate containing appropriate antibiotic and incubated  at
37 ?C overnight.
 2.2.3 1 Protein Expression
 A single colony of the bacteria was picked up into 25 ml LB broth containing  appropriate
antibiotic and incubated overnight at 37?C shaking at 240 rpm. Next day the  culture  was
moved to 200 ml LB broth for 4 to 5 hours with shaking at 240 rpm at 30 ?C.  The  protein
induction was applied using  1mM  of  IPTG.  The  cells  were  then  incubated  at  12  ?C
overnight.
The cells were spun at 10,000 g for  10  minutes  re-suspended  in  Tris-NaCl  buffer  and
they were then subjected to lysis by lysozyme, followed by freezing at -80 oC and thaw at
room temperature (three times) and then sonication for  30  second  at  maximum  power
repeated 6 times.
The proteins  were  then  centrifuged  at  10,000g  and  the  supernatant  was  taken  and
centrifuged at 200,000g for 30 minutes.
2.2.4 Bradford protein assay
The Bradford assay is a colorimetric assay for measuring total protein concentration. The
principle of this assay is measuring the absorbency  at  595  nm  for  the  protein  when  it
binds to  the  Coomassie brilliant blue G-250.
100 mg Coomassie brilliant blue G-250 was dissolved  in  50  ml  95%  ethanol,  100  ml  85%
(w/v) phosphoric acid was added then diluted to 1 litre. Ranges of 5 to 100 micrograms of
BSA protein were prepared in 20 µl volume and 1 ml dye reagent was added to each one
and incubated for 5 minutes, and the absorbance was measured at 595  nm.  A  standard
curve of absorbance data was plotted for BSA range of protein concentrations  and  used
to determine the amounts of unknown protein from the curve.
2.2.4 SDS Sample preparation
A BIO-RAD Mini-PROTEAN II Cell electrophoresis kit for home made  gels  was  used  to
perform  this  experiment.  The  resolving  and  stacking   gel   solutions   were   prepared
previously and stored at 4 °C until required;  all  the  components  were  added  with  the
exception of TEMED  and  10%  APS  (to  start  the  polymerisation),  which  were  added
immediately prior to pouring into the gel plate (see table 1).
|Components        |Resolving (10 ml)                |Stacking 10 ml  |
|(ml)              |                                 |                |
|                  |8%      |10%        |12 %         |5%              |
|H2O               |4.6     |4.0        |3.3          |6.8             |
|30% Acrylamide    |2.7     |3.2        |4.0          |1.7             |
|1.5 M Tris  pH 8.8|2.5     |2.5        |2.5          |-               |
|10% SDS           |0.1     |0.1        |0.1          |0.1             |
|10 % APS          |0.1     |0.1        |0.1          |0.1             |
|1.0 M Tris, pH 6.8|-       |-          |-            |1.25            |
|TEMED             |0.006   |0.004      |0.004        |0.01            |
Table 1 SDS sample preameration.
5x SDS Running Buffer: (1 L) Tris 15 g,  Glycine  72  g  and  SDS  5  g  Coomassie  Blue
Stain:  10%  (v/v)  acetic  acid,  0.006%  (w/v)  Coomassie  Blue  dye  and  90%   ddH2O.
Destaining Solution: 10% (v/v) acetic acid, 30% (v/v) methanol and 65% ddH2O.
2.2.4.1 Preparing an SDS gel
To prepare SDS gels, two glass plates were placed into the rack and 5 ml of the gel  was
loaded between the two plates. 100 µl of 0.1 % SDS was poured to cover the  surface  of
the  running  gel,  and  the  gel  was  left  for  20  minutes   for   polymerisation   at   room
temperature. The overlaying SDS solution was removed and  2  ml  of  stacking  gel  was
loaded. Rapidly, the comb  was placed into the space between the two glass plates.
5 X SDS sample loading buffer (40 ml) was prepared by adding ddH2O (16  ml)  into  0.5M  Tris-HCl,
pH 6.8 (5 ml), 50% Glycerol (8 ml), 0.02% bromophenol blue and 10%  SDS  (8  ml)  with
Dithiothreitol (DTT) 77 mg/ml added immediately before use.  5  µl  5  X  of  SDS  loading
buffer was added to 15 µl of each sample and heated at 95?C for 10 minutes, in  order  to
denature the proteins. The BioRad  kit  was  used  for  the  electrophoresis,  and  the  gel
cassette was immersed in the tank and covered with 1 X running buffer.
The samples were loaded into the gel and electrophoresis was applied with  voltage  of  80  volts  for  2.5
hours. The gel was stained with Coomassie Brilliant Blue R250 and de stained with  10%
acetic acid 30% methanol destain and dried at 80 oC in vacuum dryer for 2 hours.
2.2.5 Western blotting
Western Blotting Detection Kit (Amersham Life Science) was used  for  immunodetection.
Following SDS-PAGE separation, the protein was blotted to the nitrocellulose membrane.
The  gel  was  placed  onto  2  pieces  of  3MM  Whatman  paper,  and  the  nitrocellulose
membrane was placed on top of the gel and  covered  with  2  pieces  of  3MM  Whatman
paper. The cassette was  covered  with  1X  transfer  buffer  [25  mM  Tris?HCl,  192  mM
glycine, 20% methanol (v/v) and 0.1% SDS]  and run in a BioRad tank for 1 hour at 90 V.
The nitrocellulose membrane was then blocked with  100  ml  of  1×TBS  [20  mM  Tris-HCl  (pH
7.5), 500 mM  NaCl]  containing  5%  BSA  for  1  hour  blocking  solution  overnight.  The
nitrocellulose membrane was incubated with either anti- his  HRP  tag  or  anti-GST  HRP
for 45 minutes with dilution of 1:10,000 in TTBS (1XTBS+0.1% Tween 20, v/v)  then,  the
nitrocellulose was washed with TTBS for 5 minutes 5 times. ECL was added to  the  nitro
cellulose membrane in the gel doc machine to detect the  chemoluminescence  reflecting
the bands of the target protein.
2.2.6 Determination of EGFP fluorescence
50 ?l of bacterially expressed protein was transferred to a crystal cuvette and diluted with
450 ?l of  water.  Then  fluorescence  emission  (without  polarisation)  was  measured  to
determine the optimal wavelengths. EGFP has minimum emission intensity between  488
and 509 nm. Fluorescence was detected by measuring the intensity  of  the  emission  for
each expressed protein.
2.3 Examination of the recombinant protein activity
3.3.1 [3H] TCDD ligand binding assay
The principle of this assay is to determine and quantify the functionality of the  AhR  LBD;
all the steps of this assay were performed at 4°C.
 2.3.1.1 Preparation of the mouse liver cytosol
Mouse liver cytosol was used as positive control for the AhR  ligand  binding  assay.  The
mouse was killed by cervical dislocation and the liver was taken out  and  placed  into  20
ml of ice-cold buffer (150 mM KCl pH 7.4) to remove the blood from the liver sample. The
liver was cut into small pieces  using scissors and placed  in  3-fold  (w/v)  of  lysis  buffer
(MENG buffer (25 mM MOPS,  pH  7.5,  1  mM  EDTA,  0.02%  sodium  azide,  and  10%
glycerol) containing 10 mM sodium molybdate, 2 mM DTT  and  1mM  PMSF).  The  liver
pieces were then homogenized and the homogenate was centrifuged at 10,000 g  for  15
minutes and the supernatant was collected .The supernatant was further  centrifuged  for
1   hour   in   the   ultracentrifuge   and   the   supernatant   was   collected.   The   protein
concentration was measured using the Bradford assay. The liver  cytosol  was  stored  at
–80 oC until use.
2.3.1.2 Preparation of the bacterially expressed protein
The induced cells were spun and 1 g of the cell pellet was resuspended with 10 ml of ice-
cold  lysis  buffer  (MENG  buffer  containing  2  mM  DTT,  100  ?l/ml  protease   inhibitor
cocktail, 1  mM  PMSF,  and  10  mM  sodium  molybdate).  The  cells  were  lysed  using
lysozyme followed by freezing at -80 oC and  thawing  at  4  °C  three  times  followed  by
sonication for 30 minutes at maximum  power  repeated  6  times.  The  lysate  was  then
centrifuged at 10,000g and supernatant was taken and  further  centrifuged  at  200,000g
for  30  minutes  in  the  ultracentrifuge.  The   supernatant   was   collected   the   protein
concentration was determined and the sample was stored at -80 oC.
2.3.1.3 Preparation of receptor dilution
The bacterially expressed proteins  were  diluted  into  a  range  of  concentrations.  Each
protein was  diluted  into  1.0  to  0.1  mg  /ml  using  ice-cold  lysis  buffer  (MENG  buffer
containing 2 mM DTT, 100 ?l/ml protease inhibitor  cocktail,  1  mM  PMSF,  and  10  mM
sodium molybdate). A 4 mg/ml solution of  BSA  was  added  to  each  sample  to  reduce
nonspecific binding of [3H]TCDD to the AhR receptor.
  2.3.1.4 Preparation of the radioactive ligand
  The  original  stock  of  radioactive  ligand,  [3H]TCDD  has  initial  specific  activity  34.7
Ci/mmol, and a concentration of 0.929 mCi/ml. An aliquot of this stock was diluted to  535
nM with p-dioxane and was used as a master stock stored at -20°C. Further dilution to  a
final concentration 200 nM was freshly prepared prior to each experiment. For the master
stock with p-dioxane, TCAOB was used as non radioactive ligand.  3  mM  TCAOB  in  p-
Dioxane was prepared as a master stock and stored at room temperature. Prior  to  each
experiment further dilution of this master stock was made to 40 ?M in p-dioxane.
2.3.1.5 Setting up the binding reaction
Triplicate samples of 200 ?l aliquots of each receptor  preparation  were  transferred  into
an Eppendorf tube. 1  ?l  [3H]TCDD  was  added  to  each  sample.   To  test  nonspecific
binding, the same samples were prepared  at  the  same  time  with  200  nM  of  the  non
radioactive ligand .The samples were thoroughly mixed  and  incubated  for  16  hours  at
4°C.
 The samples were then treated with dextran-coated charcoal to remove  the loosely bound and
unbound  radioactive  ligand;  each  sample  was  treated  with  30?l   of   dextran-coated
charcoal (33 mg charcoal/ml in MDENG buffer) to each sample to a concentration  of  0.2
mg charcoal/mg protein. The sample was mixed and  incubated  for  10  minutes  on  ice.
The samples then were spun at 14,000g to remove the charcoal/dextran  for  10  minutes
at 4 °C.  150 ?l of supernatant was transferred from each sample into  a  scintillation  vial
containing 5 ml scintillation fluid. The sample was mixed vigorously with  scintillation  fluid
before counting.
 The radioactivity of ligand [3H]TCDD  was  detected  by  liquid  scintillation  counting  using  a
Packard  Tri-carb  Model  2100TR  Liquid  Scintillation  Analyser.  The  total  bound   was
described  as  the  radioactivity  of  ligand  that  bound  to  the  receptor  in  solution  after
charcoal treatment. Non-specific binding was described as the  bound  radioactive  ligand
in the presence of a 200-fold excess of non-radioactive competitor.  The  specific  binding
was  described  as  the  difference  between  the  total   and   non-specific   binding.   The
measurement of bound ligand (d.p.m.) was converted to molar  concentration  as  follows
(Hulme and Birdsall 1993):
 RL* = B/(V ? SA ? 2220) nM
Where B is the radioligand bound (d.p.m.)  corrected  for  counter  background,  V  is  the
volume of radioligand assayed (ml), SA is the specific activity of the radioligand.
2.4  Refolding  the  bacterially  expressed  GGA  and  GGAG  in  human
reticulocyte lysate.
The recombinant proteins were prepared as described in section 2.2.3.1. 5 ?l  aliquots  of
each protein sample were incubated  with  25  ?l  of  human  reticulocyte  lysate  at  room
temperature  for  one  hour,  and  then  the  sample   was   diluted   using   MENG   buffer
containing 2 mM DTT, 100 ?l/ml  protease  inhibitor  cocktail,  1mM  PMSF,  and  10  mM
sodium molybdate buffer to 200 ?l. [3H] TCDD specific binding  assay  was  preformed  to
test the functionality each protein as described in section 2.3.1.5.
3. Results
3.1 Optimization of cell lysis
Cell lysis is an essential step for successful purification of any expressed protein.  Many
different methods are commonly  used  to  release  recombinant  protein  from  bacterial
cells such as sonication, enzymatic lysis using lysozyme, and  freeze–thaw.  Sonication
is a wildely used technique for cell lysis but, one of the  disadvantages  of  sonication  is
overheating of the sample, resulting in protein  denaturation,  and  for  that  reason  it  is
important to place the sample in ice while sonicating. Freeze–thaw lysis, by  freezing  at
−20oC or −80 °C then thawing at room temperature, is a gentle method,  but  can  often
result in incomplete lysis (Peti and Page 2007). It was decided to use a  combination  of
different methods; lysozyme, freeze-thaw  and  sonication  for  30  seconds.  Therefore,
four different lysis methods were evaluated for their ability to release  the  proteins  from
the cells; the first method (A) was using lysozyme (B) was  using  lysozyme  and  freeze
and thaw three times, the second method (C) was using lysozyme and then  sonication,
and the last method (D) was using lysozyme and freeze then thaw three times following
by sonication. Bradford Assay was performed as described in the Material and Methods
to determine the amount of protein obtained from each method.
When comparing the efficiency of the three methods, method (C and D) were clearly more efficient
than (A) or (B) and this allowed us to obtain the  highest  protein  yields  from  the  cells.
Generally, the condition in which lysozyme is  combined  with  sonication,  gives  higher
amount of proteins extracted from the cells compared to the freeze  thaw  cycles,  when
applied independently or in combination with lysozyme.
The result showed that using lysozyme followed by freeze  then  thaw  three  times  or/  and  followed  by
sonication gives the highest yield of protein. Figure 3.1  shows  that  using  lysozyme  and  then
sonication gives 1.87mg/ml while using  lysozyme  and   freeze  then  thaw  three  times
followed by  sonication gives 1.96mg/ml.
Figure 3.1  Protein concentration result from different methods of cell lysis: 5ml of overnight bacterial culture was  diluted  in  50
ml LB broth and then incubated for three hours. The cells were  centrifuged  and  resupended  with  NaCl-Tris  buffer.  Different  lysing
methods were used to lyse the cells. The protein concentration was determined using Bradford  assay  as  described  in  Material  and
Methods. (A) lysozyme  (B) lysozyme and freeze and thaw three times (C) lysozyme and  then  sonication,  and  the  last  method  (D)
lysozyme and freeze then thaw three times following by sonication.
3.2 Expression of GG, GGA and GGAG in E. coli at 15?C
The attempts to express GGA and GGAG recombinants in BL21 D3  at  37oC  and  purify
these recombinants did not produce any success in obtaining  functional  protein.  It  was
decided to examine if the expression of GG, GGA and GGAG in E. coli Arctic Express  at
15oC  can  yield  high  levels  of  these  proteins.  Therefore  the  three   constructs   were
transformed into E. coli Arctic Express.
The three constructs GG, GGA and GGAG were transformed into  E. coli  Arctic  Express
cells. 5 ml of overnight bacterial culture were diluted with 50 ml  LB  broth  and  incubated
for 3 hours, and then the cells were induced with 1 mM IPTG and incubated  overnight  at
15 oC with shaking (see Materials and Methods).
The cells were centrifuged  and  resuspended  in  10  ml  of  Tris-NaCl  lysing  buffer  and
lysed by incubating the cells with lysozyme for 30 minutes on ice, followed by freeze  and
thaw three times, followed by sonication. The total protein concentrations of the  samples
were determined using Bradford protein assay. The total protein samples were  analyzed
using SDS PAGE.
Figure 3.2 shows three bands in the induced samples compared with un-induced  samples
and the control: the band in the GG induced sample is around 65  kDa  and  the  induced
band in the GGA sample is about 80 kDa. In the induced GGAG the band is  around  109
kDa . These are the expected sizes for the three proteins.
Figure 3.2 Expression of GG, GGA and GGAG in arctic express cells. The total protein was loaded onto SDS PAGE: In  first  lane
6H molecular weight  marker ;( 29, 45, 66, 97, 116 and 205  kDa),  lane  2  contained  untransformed  E  coli  arctic  express  cells,  I=
induced, U = uninduced.
3.3 Solubility of AhR fusion protein in bacteria
In a previous study performed in the same  lab,  using  the  same  constructs  in  order  to
obtain soluble proteins, the constructs were expressed in E coli BL21 at  37oC  and  SDS
PAGE showed no band in the soluble fraction, to examine the solubility of AhR  that  was
expressed in Arctic Express at 15 oC,  the  bacterial  cells  were  induced,  lysed  and  the
homogenate centrifuged at 10000 g for 10 minutes followed  by  further  centrifugation  at
200000g for 30 minutes,  The supernatant was taken  and  loaded  onto  an  SDS  PAGE
gel (Figure 3.3).
Figure 3.3 Expression of Induced GG, GGA and GGAG in Arctic express at 15°C. Total  protein  and  supernatant  were   loaded
onto SDS PAGE : lane  6H molecular weight  marker showing the position of 29, 45,  66,  97,  116  and  205  kD  lane  2  contained  E
coli arctic express cells, lane 3 contained induced GG total protein , lane 4 contained  induced  GGA  total  protein,  lane  5  contained
induced GGAG total protein, lane 6 contained induced GG supernatant, lane 7 contained induced GGA supernatant, lane 8 contained
induced GGAG supernatant.
From Figure  3.3  there  is  a  band  in  lane  8  with  induced  GGAG  in  the  supernatant
compared  with  total  protein  samples  and  the  control  at  about  109  kDa,  this  is  the
expected  size  for  the  GGAG  which  is  suggesting  the  solubility   of   GGAG   protein.
However, the band for GGA in the soluble fraction is not clear, and the proteins might  be
present in the soluble fractions at low concentration.
3.4 Expression of GG, GGA and GGAG in E. coli Arctic express at 37?C
To examine if the expression of GG, GGA and GGAG in 37?C could yield a high  level  of
soluble AhR, the cells were induced by 1mM of IPTG, incubated for 24 hours at 37o  C  in
the shaker and the samples were analyzed by SDS PAGE. Expression of GG,  GGA  and
GGAG at 37?C showed three expected bands in the total proteins as  well  as  the  pellet
(after 10000g centrifugation) at sizes 66, 84 and 109 kDa. Figure 3.4.
Figure 3.4 Expression of Induced GG, GGA and GGAG in E. coli Arctic Express at 37°C.  Total  protein,  pellet  and  supernatant
were  loaded into SDS PAGE: lane1 6H molecular weight  marker showing the position of 29, 45, 66, 97,  116  and  205  kDa,  lane  2
contained E coli Arctic Express cells, lane 3 contained induced GG total protein, lane 4 contained induced GGAG total protein, lane  5
contained induced GGA total protein, lane 6 contained induced GG supernatant, lane 7 contained induced GGA  supernatant,  lane  8
contained induced  GGAG  supernatant,  lane  9   contained  induced  GG  pellet,  lane  10  contained  induced  GGA  pellet,  lane  11
contained induced GGAG pellet
Figure 3.4 shows three bands in the induced samples in the total  protein  and  the  pellet
compared with the control: the first band in the GG induced sample is around 60 kDalton,
the second induced band in the GGA sample is about 84  kDa  and  the  induced  GGAG
band  about  109  kDa.  These  are  the  expected  sizes   for   the   three   proteins.   The
supernatant samples did not show any solubility of  these  proteins  presumably  because
37 oC expression can decrease the cell’s ability to fold the protein properly.
3.5 Expression of GG, GGA and GGAG in E. coli BL21 D3 at 37?C
To examine if the expression of GG, GGA and GGAG in a different strain of E  coli  could
obtain soluble AhR compared to Arctic Express, the  three  constructs  were  transformed
into BL21 D3 cells. The cells were induced by 1 mM IPTG and incubated for 24  hours  at
37oC in the shaker (see Materials and Methods) and the samples were analyzed by  SDS
PAGE.
The cells were spun at 10000 g for 10 minutes, re-suspended in  Tris-NaCl  buffer,  subjected
to lysis by lysozyme and freezing at -80oC  and  thaw  one  time,  then  sonication  for  30
seconds  at  maximum  power.  The  samples  were  then   centrifuged   at   10000g,   the
supernatant was taken and centrifuged at 200.000g for 30 minutes  and  all  the  samples
were loaded into SDS PAGE.
Expression of GG, GGA and GGAG at 37?C showed three expected  bands  only  in  the
total protein are 66, 84 and 109 kDa (Figure 3.5).The supernatant samples did  not  show
any solubility of these proteins.
Figure 3.5 Expression of Induced GG, GGA and GGAG in BL21 D3 at 37oC. Total protein and supernatant were  loaded into  SDS
PAGE : lane  6H molecular weight  marker showing the position of 29, 45, 66, 97, 116 and 205  kDa,  lane  2  contained  E  coli  BL21
cells, lane 3 contained induced GG total protein, lane 4 contained induced GGA total protein, lane  5  contained  induced  GGAG  total
protein, lane 6 contained induced control BL21 supernatant, lane7 GG supernatant, lane 8 contained induced GGA supernatant,  lane
9 contained induced GGAG supernatant.
3.6.1 Purification of GG, GGA, and GGAG
The GST SpinTrap Purification kit  was  used  to  purify  the  proteins  from  the  soluble
fraction. Based on the affinity for GST tag were used to  purify  these  proteins.  5  ml  of
each overnight Arctic express culture was diluted to 200 ml and incubated for 4 hours at
30oC.
The cells were induced by adding 1 mM IPTG and incubated  overnight  at  15o  C.  The
cultures were centrifuged at 10000g to sediment the cells and re-suspended in 10 ml  of
ice-cold 1× PBS, and then the cells were lysed using lysosyme,  freeze  and  thaw,  and
sonication.
 The homogenate was spun to remove insoluble material. 600 ?l of the supernatant was
transferred to Glutathione Sepharose 4B MicroSpin columns and spun  for  1  minute  at
735 × g. The columns were washed with 600 ?l PBS and spun. This step was  repeated
three times. 100–200 ?l of glutathione elution buffer  was  added  to  each  column,  and
incubated at room temperature for 5–10 minutes.
Each eluate was collected by centrifugation for one  minute  at  735  ×  g.  The  proteins
were analysed using SDS PAGE.
From figure 3.6.1 it can be  observed  that  the  three  proteins  were  successfully  purified
from the soluble fraction, with the expected sizes for the GG, GGA, and GGAG  purified
proteins compared with unpurified proteins.
Figure 3.6.1 Purification of the three constructs using GST Tag: lane 1  6H molecular weight  marker showing the position  of  29,
45, 66, 97, 116 and 205 kDa, lane 2 contained GG purified protein, lane 3 contained GGA purified  protein,  lane  4  lane  3  contained
GGAG, lane 5 contained induced GG unpurified  protein, lane 6 contained  GGAG  unpurified   protein,  and   lane  7  contained  GGA
unpurified  protein.
3.6.2 Detection of the protein fluorescence
The  fluorescence  intensities  of  the  purified  expressed  proteins  were  measured   to
confirm the presence of EGFP. The emissions  of  the  protein  samples  were  scanned
between 500 to 600 nm with excitation at 450 nm. EGFP-AhR constructs showed peaks
at 510 nm unlike the controls which had a peak around 540.
50  µl  of  the  purified  protein  was  diluted  to  500  µl  with  water  and  the  fluorescence
intensity was scanned. Arctic express bacterial lysate was used as a negative control.
The expressed proteins had a fluorescence emission with peak around 510 nm (Figure 3.6.2).
Figure 3.6.2 Fluorescence spectra for the purified proteins. 50 µl of the purified protein was diluted to 500 µl and the fluorescence
intensity was scanned between 500 to 600 nm and excitation at 450nm. Arctic express lysate was used as negative control
3.6.3 Mass spectrometry analysis for GG, GGA, and GGAG
GG, GGA, and GGAG proteins were analyzed by mass spectrometry in order to confirm
the identity of these expressed proteins. The purified  proteins  were  loaded  onto  10%
SDS-PAGE.
The expected bands of the proteins on the gel were cut. The samples were subjected to
tryptic digestion and the  sizes  of  tryptic  fragments  were  identified  by  the  molecular
mass of the  ion  within  0.1Da  mass  unit  of  the  predicted  size.  Table  3.2  shows  a
significant matching of the tryptic fragment with the three proteins (p<0.05).
In GG protein analysis, there were four specific fragments matched  with  the  GFP  and
three fragments matched with the GST, which confirms the band was GG protein. In the
second protein which was expected to be GGA, there were two  fragments  matched  to
GST, two fragments matched to the LBD and one fragment matched to the  GFP  which
also  confirmed  the  existence  of  GGA  protein.  In  GGAG  proteins  there   were   two
fragments matched to the LBD, one matched to the GST and another matched to  GFP,
which is indicating that this band is GGAG protein.   
|Peptide                          |Mr(expt)   |Mr(calc)   |Residues|Protein |
|                                 |           |           |        |matched |
|GG                                                                          |
|K.SAMPEGYVQER.T                  |1265.5682  |1265.5710  |397-410 |GFP     |
|K.FSVSGEGEGDATYGK.L              |1502.6522  |1502.6525  |338-356 |GFP     |
|R.TQISSSSFEFCSR.R +              |1534.6736  |1534.6722  |550-567 |GFP     |
|Carbamidomethyl (C)              |           |           |        |        |
|K.LTQSMAIIR.Y + Oxidation (M)    |1047.5718  |1047.5746  |63-74   |GST     |
|.MSPILGYWK.I                     |1093.5608  |1093.5630  |1-9     |GST     |
|R.AEISMLEGAVLDIR.Y               |1515.8004  |1515.7966  |88- 102 |GST     |
|GGA                                                                         |
|R.IEAIPQIDK.Y                    |1025.5694  |1025.5757  |181-192 |GST     |
|K.LTQSMAIIR.Y + Oxidation (M)    |1047.5788  |1047.5746  |63-74   |GST     |
|K.TGESGMTVFR.L                   |1083.5014  |1083.5019  |640-651 |AhR     |
|K.TGESGMTVFR.L + Oxidation (M)   |1099.4928  |1099.4968  |640-651 |AhR     |
|K.SAMPEGYVQER.T                  |1265.5682  |1265.5710  |397-410 |GFP     |
|GGAG                                                                        |
|K.SAMPEGYVQER.T                  |1265.5682  |1265.5710  |397-410 |GFP     |
|K.LTQSMAIIR.Y + Oxidation (M)    |1047.5788  |1047.5746  |63-74   |GST     |
|K.TGESGMTVFR.L                   |1083.5014  |1083.5019  |640-651 |AhR     |
|K.TGESGMTVFR.L + Oxidation (M)   |1099.4928  |1099.4968  |640-651 |AhR     |
Table 3.2 summary of TOF-MS. Tryptic analysis of the three expressed AhR constructs (GG, GGA and  GGAG)  .Sample  were
tryptic digested and analysed by TOF-MS.  The size of Tryptic fragments were predicted depending on the molecular mass of  the  ion
within 0.1Da mass. The table shows the specific matching of the peptides to sequence  within  the  proteins.  The  hits  were  matched
using Mascot Search http://www.matrixscience.com p<0.05
3.6.4 Conformation of the protein specificity by western blot
The proteins were separated  on  10%  SDS-PAGE  as  described  in  the  Material  and
Methods  section  and  the  gel  was  transferred  onto  nitrocellulose   membrane.   The
membrane was blocked with the blocking  solution,  the  membrane  was  then  washed
three times in TTBS, and then incubated in His-tag antibody solution in TTBS for 1 hour
then washed three times. The blot was detected using  the  Western  Blotting  Detection
kit.
In figure 3.6.3 three bands of the  expected  size  are  observed  for  the  three  proteins
which have His-tag compared to the negative control.
Figure 3.6.3 Detection of Recombinant AhR GG, GGA and GGAG by Western Blotting. Induced Arctic express  cells,  GG,  GGA
and GGAG proteins were run on 10% SDS-PAGE then blotted to nitrocellulose membrane. Lane 1 (control)  contained  induced  cells.
Lane 2 GG protein, Lane 3 GGA and Lane 4 GGAG.
3.7 The Ligand Binding Assay
This experiment aimed to examine the functionality of the  AhR  LBD  constructs,  and  to
quantitate the ligand binding  activity  of  these  constructs  using  an  in  vitro  radioligand
binding assay.
The main idea of this binding  assay  is  to  perform  the  experiment  in  the  presence  of  a  constant
concentration of ligand and receptor. The unbound and loosely bound  ligand  should  be
removed and at equilibrium the binding activity is calculated. Therefore it  is  important  to
optimise experimental conditions.
3.7.1 Optimization Ligand Binding Assay
Mouse liver cytosol was used as a source of AhR receptor. Triplicate samples of 200?l of
the mouse cytosol protein were used in this assay. 1 ?l aliquot  of  1  nM  [3H]TCDD  was
added to each sample.
To test  non-specific  binding,  a  1  ?l  aliquot  of  [3H]TCDD  and  200-fold  excess  of  TCAOB
competitor were added to each sample; the samples were mixed and then  incubated  for
16 hours at 4 °C. A 30 ?l aliquot of each  sample  was  transferred  to  a  scintillation  vial
containing 5ml of scintillation fluid and the samples were  analysed  by  liquid  scintillation
counting.
The remaining sample in each tube was treated with dextran-coated charcoal  to  remove
unbound and loosely bound ligands. 30 ?l of dextran-coated charcoal (33 mg charcoal/ml
in MDENG buffer) was added to each sample; the sample was mixed, and  incubated  on
ice for 10 minutes followed by centrifugation for 10 minutes at 14,000g at 4 °C. A  150  ?l
aliquot of supernatant was transferred to a scintillation  vial  containing  5  ml  scintillation
fluid. The sample was mixed vigorously and analysed by liquid scintillation counting.
3.7.1.1 The effect of protein concentration
To determine the amount of protein receptor binding to TCDD, and to  decide  how  much
protein concentration could be  used  in  the  binding  assay,  different  concentrations  of
mouse liver cytosol (5, 7, and 10 mg/ml) were incubated at 4 °C with 1 nM  [ 3H]TCDD  in
the presence or absence of a 200-fold excess of competitor TCAOB.
Samples were incubated for 16 hours, followed by charcoal-dextran treatment to  remove
unbound ligand. A 150 ?l aliquot of each sample was analysed  by  scintillation  counting.
Total, nonspecific and specific binding were determined.
Figure 3.7.1 shows that there was a specific binding of [3H]TCDD to mouse liver cytosol, at
different protein concentrations ranging from  0.5  to  7  mg/ml.  The  determined  binding
capacities of mouse cytocol AhR using different  protein  concentration  were  45.2,  31.5,
22.4 and 16.7  fmol/mg  for  0.5,  2,  5,  and  7  mg  protein  concentrations.  Figure  3.7.1
concludes using lower protein concentrations appears to give a higher binding capacity.
Figure 3.7.1 the effect of protein concentration. Different concentration of mouse liver cytosol (0.5, 2, 5 and  7  mg/ml)
were incubated at 4°C with 1nM [3H] TCDD in the presence or absence of a 200-fold excess of competitor  TCAOB  as  described  in
Material and Method. Samples were incubated for 16h,  followed  by  charcoal-dextran  treatment  to  remove  unbound  ligand.  150?l
Aliquot of each sample was analysed by scintillation counting. Total, nonspecific and specific binding were determined.
3.7.2 Binding assay standard Curve
A [3H]TCDD standard binding assay was  performed  to  determine  the  apparent  affinity
constant (Kd) and the maximum concentration of specific binding sites, Bmax. 5 mg/ml of
mouse liver cytosol aliquot was incubated with several concentrations of [3H]TCDD (0-2.0
nM) in the presence and absence of 200-fold molar excess TCAOB and incubated for  16
h at 4 ºC. 30 ?l of dextran-coated charcoal (33  mg  charcoal/ml  in  MDENG  buffer)  was
added after the 16-hours incubation and radioactivity measured.
The analysis of saturation binding curve was plotted using nonlinear regression  for  single  site
binding hyperbola analysis in GraphPad Prism version 5.
Figure 3.7.2 shows that [3H]-TCDD specific binding to mouse cytosol  started  to  be  stable
at [3H]-TCDD concentration ? 1 nM. The apparent Kd  for  specific  binding  of  [3H]TCDD
was 0.50 ± 0.07 nM (103 fmol/mg) and the concentration of binding sites, Bmax was 0.23
± 0.01 nM (46 fmol/mg).
Figure 3.7.2 Specific Binding of [3H]TCDD to mouse liver cytosol: Range of  0 to 2.0 nM [3H]TCDD were  incubated  with  5mg/ml
of mouse liver cytosol in the presence and absence of a 200-fold excess of competitor TCAOB. After 16h incubation  at  4C,  unbound
and loosely bound radioligand was  removed  by  charcoal-dextran  treatment,  specific  binding  data  were  plotted  to  show  specific
binding capacities (fmol/mg cytosol protein). Each point represents the average of triplicate samples.  Data were analysed  using  one
site binding / GraphPad Prism version 5.
3.7.3 The specific Binding of [3H]TCDD to GG, GGA and GGAG
The aim of this experiment is to  quantify  the  functionality  of  the  bacterially  expressed
proteins.
200 ?l aliquots of each protein sample were incubated with 1 ?l [3H]TCDD in  triplicate.   To
test non-specific binding, the same samples were prepared at the same time with 200 nM
of the non radioactive ligand and incubated for 16 hours at 4 °C.
 The samples were then  treated  with  Dextran-coated  charcoal  to  remove  the  loosely  bound  and
unbound  radioactive  ligand;  each  sample  was  treated  with  30  ?l  of  dextran-coated
charcoal
In Figure 3.7.3,  it  can  be  seen  there  is  no  specific  binding  within  the  three  protein
samples compared to the controls. The binding  capacity  for  RCL  (Rat  liver  cells)  was
45.2 fmol/mg whereas in the GGA the binding capacity was very low (5 fmol/mg)  and  no
binding capacity was detected in GGAG.
Figure 3.7.3 Specific binding of [3H]TCDD to GG, GGA, and GGAG: liver cytosol was used as  positive  control,  BSA  and  GG  as
negative control. The proteins were  incubated  with  [3H]TCDD  in  presence  and  absence  of  a  200-fold  excess  of  TCAOB  as  a
competitor for 16h incubation at 4 oC, free radioligand  was  removed  by  charcoal-dextran  treatment  and  the  specific  binding  was
detected
3.8  Refolding  the  bacterially  expressed  GGA  and  GGAG  in  Human
reticulocyte lysate.
The recombinant proteins were prepared as described in section 2.2.3.1. 5 ?l  aliquots  of
each protein sample were incubated  with  25  ?l  of  human  reticulocyte  lysate  at  room
temperature for one hour, and then the sample was diluted using MENG buffer to 200  ?l.
[3H]TCDD specific binding assay was preformed to test the functionality each protein.
Figure 3.8 shows the radioligand binding activity  in  each  protein;  there  was  a  binding
activity around  0.022  nmol  in  both  GGA  and  GGAG  sample  compared  with  control
samples
Figure 3.8 Refolding the bacterially expressed GGA and GGAG in Human reticulocyte lysate. 5 ?l aliquots of each protein
sample were incubated with 25 ?l of human reticulocyte lysate at room temperature for one hour, and then the sample was diluted to
200 ?l. [3H]TCDD specific binding assay was preformed to test the functionality each protein
4- Discussion
4.1 GGA and GGAG expression
Fusion proteins are used to facilitate  the  identification  and  the  purification  of  proteins.
Examples include fusing to a GST tag or His tag (Uhlen et al., 1983), to improve the yield
of a recombinant protein (Butt et al., 1989) and to improve the solubility of a  recombinant
protein  by  fusing  to  a  highly   soluble   partner   that   would   help   the   proteins   fold
independently  and   functionally   (Schein   and   Noteborn,   1988).   GGA   and   GGAG
recombinant proteins were originally made by Shaikh-Omer (2006) by fusing one  or  two
EGFP proteins to mouse AhR LBD and tagged  with  GST  protein.  EGFP  was  used  to
enhance the solubility of the LBD and GST-EGFP was used as a control.
E. coli strain BL21 D3 is widely used to express  recombinant  proteins  since  it  is  easy,
cheap and yields a high level of  protein.  However,  the  attempts  to  express  GGA  and
GGAG recombinants in BL21 D3 at  37  oC  did  not  produce  any  success  in  obtaining
functional protein (Shaikh-Omer 2006).
The difficulty when  trying  to  express  LBD  recombinant  proteins  in  BL21  D3,  results  in
incorrectly folded proteins and aggregations called  inclusion  bodies.  Normal  cultivation
temperature for the E. coli could decrease the  cell’s  ability  to  fold  the  protein  properly
(Miyake et al., 2007). Therefore,  by  lowering  the  cultivation  temperature,  the  proteins
could be expressed and fold correctly in Escherichia coli (Annamalai et al., 2009).
It has been demonstrated that expression  at  a  low  temperature  condition,  increases  the  stability  of  the
fusion protein. In addition, it also limits the toxic effect of T7 driven expression (Mujacic et al.,  1999).
Arctic express strain (Stratagene) was chosen for this purpose because  of  tt‘s  ability  to
grow at lower temperatures. Arctic  express  strain  has  been  genetically  engineered  in
order  to  introduce  two  proteins  known   as   cold-adapted   Chaperonins.   This   strain
specifically  produced  Chaperonin  Cpn60  and  co-chaperonin   Cpn10   from   Oleispira
antarctica. It was demonstrated that co-expression of the  Chaperonins  facilitates  grown
at lower temperatures (4-15 oC) and helps the recombinant proteins to fold correctly;  this
was proven to be 180 fold more than that expressed in an ordinary E.  coli  strain  (Ferrer
et al., 2004).
In this study it has been confirmed that the expression of GGA and GGAG in E. coli Arctic Express  at
15 oC yields soluble proteins.  Figure  3.3  shows  three  bands  in  the  induced  samples
compared with un-induced samples and the control.  There  can  be  seen  clearly  in  the
soluble fraction a band at 112 kD, consistent with GGAG’s  size,  and  this  suggests  that
band is GGAG.
To guarantee that the protein in the soluble fraction was not a  contamination  from  the  pellet,  the  soluble
fraction was further centrifuged at 240,000 x g for 30 minutes. This  result  suggests  the  solubility  of  this
protein. However, the GGA band in the soluble  fraction  was  not  clear;  this  could  be  explained  by  the
possibility  that  protein  present  in  the  soluble  fractions  was  at  a  low  concentration,  in
agreement with Alshikh- Omer (2006) who also suggested  that  the  GGA  was  not  very
soluble.
The soluble protein co-expressed with the chaperonin related to the lower  temperature  expression  not  the
chaperonin-mediated the folding (Ferrer et al.,  2004).  Expression  of  GGA  and  GGAG  in  E.
coli Arctic Express at 37 oC did not show any protein  solubility  compared  with  the  total
protein in the pellet, which suggests that the solubility of the protein was  not  because  of
the chaperonin but because of the low temperature (figure 3.4).
4.2 Optimization of cell lysis
Three different lysis methods were evaluated in order to release  the  highest  amount  of
the recombinant expressed protein. These methods  were  enzymatic  lysis  by  lysozyme
treatment, sonication, and freeze–thaw.
Freeze–thaw is an effective method, done by re-suspending the cells  in  lysis  buffer  and  then  freezing  at
−80 oC followed by thawing on ice. This was repeated three times. This  method  is  gentle
and it is recommended for E. coli expression. However, this method does  not  guarantee
a complete lysis of the cells (Peti and Page, 2007). On  the  other  hand,  sonication  is  a
powerful method widely used for cell lysis. Although the maximum yield of protein can  be
produced by this technique, the disadvantage of this procedure is that  the  sample  could
overheat if the sonication was applied for a long time,  resulting  in  protein  denaturation.
To overcome this problem, it was necessary to reduce the sonication  time  and  to  place
the sample on ice while sonicating (Joersbo and Brunstedt, 1990).
Therefore, it was decided to use a combination of  different  methods;  lysozyme,  freeze-
thaw  and  sonication  for  30  seconds.  When  comparing  the  efficiency   of   the   three
methods, using lysozyme followed by  freeze  then  thaw  repeated  three  times  or/  and
followed by sonication, gave the highest yield of protein 1.96 mg/ml.
4.3 Purification of GG, GGA, and GGAG
GST  tag  facilitates  a  high-quality  purified  protein  from  cell  extracts.  Glutathione   S-
transferase  fusion  protein  can  be  purified  easily  from  the  bacterial   lysates   without
denaturing the protein by immobilising the GST in affinity column (Johnson et al., 1988).
The GST Spin Trap Purification kit is a GST pre packed column (from GE  Healthcare).  This  system  was
used  to  purify  the  soluble  proteins  from  the  bacterial  crude  extraction.  In  Figure  3.6.1  it  can  be
observed from the SDS PAGE analysis, that the three proteins were successfully purified
from the soluble fraction, with the expected sizes for the GG,  GGA,  and  GGAG  purified
proteins compared with un-purified proteins. Protein  eluted  was  quantified  by  Bradford
assay and nearly half of the soluble protein was recovered in both GGA and GGAG. This
proves that the protocol used was successful and  both  proteins  could  be  found  to  be
soluble GGA and GGAG. Comparing  this  result  with  Skaikh-Omer  (2006),  he  did  not
purify any bacterially expressed proteins, probably because of the very  low  level  of  the
soluble protein.  The purification of GGA and the GGAG was confirmed by  western  blot,
fluorescent detection and Mass spectrometry analysis
In figure 3.6.3 three bands of the expected size are observed for the  three  proteins  which
have  His-tag  compared  to  the  negative  control.  The  fluorescence  intensities  of  the
purified expressed proteins were also measured to confirm the presence  of  EGFP.  The
emissions of the protein samples were scanned  between 500 to 600  nm  with  excitation
at 450 nm. EGFP- AhR constructs showed peaks at  510  nm  unlike  the  controls  which
had a peak around 540.
Mass  spectrometry  analysis  confirms  the  identity  of  GG,  GGA,  and  GGAG  proteins.   There  was   a
significant  matching  of  the  tryptic  fragments  with  the  three  proteins   (p<0.05).   In   GG   protein
analysis, there were four specific fragments matched with the GFP  and  three  fragments
matched with GST, which is consistent with the expected structure of the GG protein, the
second band which was expected to  be  GGA,  there  were  two  fragments  matched  to
GST, two fragments matched to the LBD and a fragment matched to the GFP, consistent
with GGA protein. In GGAG bands there were two fragments matched  to  the  LBD,  one
matched to the GST and another matched  to  GFP  indicating  that  this  band  is  GGAG
protein.
4.4 The Ligand Binding Assay
The in  vitro  AhR  binding  has  been  reported  in  different  papers  as  an  approach  to
investigate the functionality of the AhR. A number  of  methods  have  been  described  to
characterize the in  vitro  AhR  binding,  such  as  using  [3H]TCDD  (Poland   et  al  1976;
Bradfield and Poland 1988) or using [125I]  2-iodo-2,3-dibromodibenzo-p-dioxin  (Bradfield
et  al.,  1988).  In  this  study,  AhR  was  treated  with  [3H]TCDD   followed  by   charcoal
adsorption and then centrifugation to remove the free radioligand and the non specifically
bound   radioligand,  and  determining  the  binding  kinetics  of  AhR  binding.   Triplicate
samples of Mouse liver cytosol  were  used  as  a  source  of  AhR  receptor  and  protein
concentration was determined to relate protein concentration to the binding assay.
Protein concentration is an important parameter affecting the result of the binding  assay.
The specific binding of [3H]TCDD to mouse liver cytosol was  increased  by  lowering  the
concentration of protein.  The binding capacities  of  mouse  AhR  using  different  protein
concentration were measured as 45.2, 31.5, 22.4 and 16.7 fmol/mg for 0.5,  2,  5,  and  7
mg/ml protein concentrations (finger 3.7.1). This result was consistent with Bradfield  and
colleagues‘(1988) work, which found that lowering  the  protein  concentrations  improves
the specificity of AhR binding the using the radioligand [3H]TCDD . (Bradfield et al, 1988)
The apparent Kd for specific binding of [3H]-TCDD  was  0.52±0.06  nmol  (103  fmol/mg)
and the concentration of binding sites, Bmax,  was  0.23±  0.01  nmol  (46  fmol/mg).This
assay is robust and it‘s results are  reliable  with  other  research  that  used  mouse  AhR
giving  Kd of  0.37 nmol af Bmax 40 fmol/mg ( Bazzi 2008) and  a Kd   0.27  nmol   Bmax
of 84 fmol/mg (Poland et al,1976 ).
4.5 Refolding the bacterially expressed GGA, GGAG in Human
reticulocyte lysate
The  bacterially  expressed  AhR  LBD  was  not  functional  because  of  the  lack  of  the
chaperones; on the other hand expression of the AhR LBD in a  eukaryotic  system  such
as reticulocyte lysate was functional (Shaikh-Omar, 2006). However, expression  of  AhR
LBD in mammalian cells yields a  very  low  amount  of  funcional   AhR  protein  (Shaikh-
Omar, 2006).
 It  has  been  established  that  chaperone  proteins  are  necessary  for  AhR  protein  to
behave functionally, by preventing the aggregation of the AhR protein.  Hsp90  is  one  of
the most important proteins it is required for  proper  folding  AhR  and  regulation  of  the
AhR function (Pongratz et al. 1992; Carver et al. 1994; Whitelaw et al. 1995).
Hsp90 shows similar regulatory activities to the  AhR  and  glucocorticoid  receptors,  and
both of them depend on Hsp90 to fold in  the  correct  conformation  (Pratt,  1997).  In  an
experiment to refold the  glucocorticoid  receptor  in  reticulocyte  lysate,  incubating  it  in
reticulocyte lysate refolds the receptor in a binding conformation that  is  needed  to  bind
the hormone (Dittmar et al., 1997).
In this study, bacterially expressed AhR LBD was refolded in Human  reticulocyte  lysate;
the GGA and GGAG refolded proteins were tested  using  a  ligand  binding  assay.  Both
GGA and GGAG were functional and bound to the radioactive TCDD.
Finally, this study established the expression of GFP AhR (LBD)  recombinant  protein  to
enable study  the  interaction  of  AhR  with  associated  chaperone  protein  by  pulldown
experiments to separate all the proteins associated with  the  AhR  LBD.  The  associated
proteins  can  be  separated  on  SDS  PAGE  and  then  sequence  them  using  MS-MS
sequencing.
Also enable to investigate the change in AhR conformation after the ligand binding of  the
AhR and  using  fluorescence  analytical  techniques  such  as  Fluorescence  Correlation
Spectroscopy (FCS) and Fluorescence Resonance Energy Transfer (FRET).
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